Summit Therapeutics Inc.SMMT

Close of Friday, October 23, 2026 · Summit Therapeutics Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.

Price

$15.47

vs its Pivot

-4.7%

OnlyAlpha Score

Trend

Below its Pivot

Last 12 months. Solid line: price. Dashed green: the Pivot.

Returns

1 month	Year to date	1 year	3 years / yr	5 years / yr
-5.5%	-11.5%	-19.2%	+101.5%	+24.6%

No dividend in the last 12 months.

Who runs and owns it

Run by Robert Duggan, Maky Zanganeh (co-CEOs, controlling holders), one of the Forbes billionaires.

In these funds

IBB · 0.18%IYH · 0.04%IYY · 0.00%

Big investors that own it (latest 13F)

Baker Bros. Advisors

2.4% of holdings

Healthcare · Biotech

ACET -49%ALNY -23%ARGX +2%ARWR -19%ASND +3%AXSM -28%BBIO -6%BCAX -20%BIIB +26%BMRN -4%BNTX -10%CORT +17%

Get SMMT in your free daily emailAfter every close: whether SMMT is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track SMMT free → Full Stock check